Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S3A pseudogene 3 (RPS3AP3) is a non-protein-coding processed pseudogene located on human chromosome 20 (chr20:37021743-37021984, hg38). Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from retrotransposition or duplication events and accumulate disabling mutations. RPS3AP3 is related to the functional RPS3A gene that encodes 40S ribosomal protein S3a, a component of the 40S small ribosomal subunit, but RPS3AP3 itself is not expressed as a protein and is not classified as a receptor, enzyme, transporter, or any other canonical drug target class. RPS3AP3 is a pseudogene and is not a therapeutic or biological target, nor does it possess any known biological functions or disease roles. There are no drugs, biomarkers, mechanisms of action, or safety concerns associated with RPS3AP3, as it is non-functional. Human genome contains multiple pseudogenes for ribosomal proteins, including RPS3A, and RPS3AP3 is one such processed pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S3A pseudogene 3 (RPS3AP3).